Home Link
Global
Omega-3
Home Link
Global
Omega-3
TOP
Global
Omega-3

 

Omega-3 solutions for the 
pharmaceutical industry

Omega-3 Pharma Solutions

Global
Omega-3

Leading the omega-3 pharma market

Reference standard for prescription omega-3-acid ethyl esters

Over two decades ago BASF introduced to the market Omacor®/Lovaza™, the first FDA and EU approved omega-3 based prescription drug. Our product is now represented in over 80 countries. We became world leaders in high-concentrate Omega-3 fatty acids for pharmaceuticals. 
Prescription omega-3s are shown to improve:

  • Hypertriglyceridemia
  • Post-myocardial infarction

We offer generic omega-3-acid ethyl esters (K85EE) as an Active Pharmaceutical Ingredient (API).

BASF delivers premium products

  • Pioneering in pharmaceutical use of omega-3
  • Long history of production and delivery of Omacor®/LovazaTM, the first FDA and EU approved omega-3 based prescription drug
  • World leading expertise, experience & support for: analysis, regulatory control, production and supply
  • Long-term strategic commitment to the business

Omega-3-acid ethyl esters (K85EE)

K85EE omega-3-acid ethyl esters contains a minimum 43% EPA and 34% DHA and minimum 90% of total omega-3-acid ethyl esters.

Chemically Eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester, this API complies with the European pharmacopoeia (Ph Eur.), US pharmacopoeia (USP) and FDA Draft Guidance on Omega-3-Acid Ethyl Esters. K85 EE is documented in a CEP and a US-DMF.

Omega-3-acid ethyl esters capsules 1g

We also offer omega-3-acid ethyl esters in 1g capsules, simplifying your supply chain.

Research & Development

20 years of experience in pharma

Value-Chain Management

Trusted collaboration with our partners

GMP sites

ALL IN-HOUSE: Streamlined production process covers the full cycle from crude oil to concentrates and capsules

Sustainability & Traceability

Our product – made from fish oil – can be traced along the entire value chain, back to healthy fish stocks

Regulatory Affairs

Dedicated to omega-3

Download Center

Discover our Product Range

Product Product Details
K85EE Information & Certificates
K85EE Omega-3-acid ethyl esters Information & Certificates
Omega 3 fatty acid ethyl ester Information & Certificates

Our Solutions

Omega-3 Pharma Solutions

BASF pioneered the Omega-3 pharma market by introducing, in 1994, Omacor®/LovazaTM as the first prescription omega-3 drug with approval from the FDA/EU. We became world leaders in high-concentrate Omega-3 fatty acids for pharmaceuticals.

Value Chain Solutions

Based on our expertise, we can offer expert knowledge and ownership of the whole value-chain and a team that proactively support supply chain management and knowledge in coordination with our partners and customers.

Softgels Platform

Functional solutions for all soft gel parts – fill, shell and coating.